Holocene Advisors’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.94M | Buy |
+527,943
| New | +$5.94M | 0.01% | 342 |
|
2025
Q1 | – | Sell |
-611,556
| Closed | -$6.88M | – | 780 |
|
2024
Q4 | $6.88M | Sell |
611,556
-1,433,050
| -70% | -$16.1M | 0.02% | 332 |
|
2024
Q3 | $57.8M | Sell |
2,044,606
-1,031,121
| -34% | -$29.2M | 0.23% | 128 |
|
2024
Q2 | $58.8M | Sell |
3,075,727
-115,576
| -4% | -$2.21M | 0.25% | 124 |
|
2024
Q1 | $105M | Buy |
3,191,303
+393,412
| +14% | +$12.9M | 0.38% | 87 |
|
2023
Q4 | $92.4M | Buy |
2,797,891
+510,792
| +22% | +$16.9M | 0.36% | 95 |
|
2023
Q3 | $62.3M | Buy |
2,287,099
+338,474
| +17% | +$9.22M | 0.27% | 113 |
|
2023
Q2 | $59M | Buy |
1,948,625
+354,872
| +22% | +$10.8M | 0.25% | 116 |
|
2023
Q1 | $51.7M | Buy |
1,593,753
+32,400
| +2% | +$1.05M | 0.25% | 125 |
|
2022
Q4 | $43.8M | Buy |
+1,561,353
| New | +$43.8M | 0.27% | 115 |
|